Comparative Pharmacology
Head-to-head clinical analysis: CHILDREN S MOTRIN versus INDICLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHILDREN S MOTRIN versus INDICLOR.
CHILDREN'S MOTRIN vs INDICLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis, thereby decreasing pain, fever, and inflammation.
Alkylating agent that crosslinks DNA, inhibiting DNA replication and transcription.
200-400 mg orally every 6-8 hours as needed; maximum 1200 mg/day without prescription, extended release forms: 600-800 mg orally twice daily.
INDICLOR is not a recognized drug; no standard dosing available.
None Documented
None Documented
2-4 hours in children; prolonged in neonates and hepatic impairment.
Terminal elimination half-life is 12 hours (range 10-15 hours) in patients with normal renal function; prolonged in renal impairment (up to 25 hours in severe cases).
Renal (90%) as inactive metabolites and conjugates; fecal (<5%).
Primarily renal excretion (approximately 70% unchanged drug); biliary/fecal excretion accounts for about 10-15% as metabolites.
Category C
Category C
NSAID
NSAID